Prudential Financial Inc Neuronetics, Inc. Transaction History

Prudential Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.73 - $4.81 $2,076 - $5,771	-1,200 Reduced 5.56%	20,400 $36,000
Q1 2024 May 14, 2024	SELL	$2.68 - $4.8 $2,144 - $3,840	-800 Reduced 3.57%	21,600 $102,000
Q3 2023 Nov 13, 2023	BUY	$1.29 - $2.22 $11,610 - $19,980	9,000 Added 67.16%	22,400 $30,000
Q2 2023 Aug 11, 2023	BUY	$2.07 - $2.92 $27,737 - $39,128	13,400 New	13,400 $28,000
Q4 2022 Feb 14, 2023	SELL	$2.74 - $6.87 $4,932 - $12,366	-1,800 Reduced 12.68%	12,400 $0
Q3 2022 Nov 04, 2022	BUY	$2.35 - $4.66 $33,370 - $66,172	14,200 New	14,200 $45,000

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $19.2M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.